Ctsd (Cathepsin D) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
CATHESPIN D is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of CATHESPIN D is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The CTSD gene encodes Cathepsin D, a lysosomal aspartyl protease that plays essential roles in protein degradation, antigen processing, and cellular homeostasis. Cathepsin D is one of the major lysosomal proteases and is involved in various cellular processes relevant to neurodegeneration.
Cathepsin D functions as:
- Aspartyl Protease: Active at acidic pH in lysosomes
- Protein Degradation: Cleaves proteins for recycling
- Amyloid Processing: Involved in amyloid precursor protein processing
- Autophagy: Essential for proper autophagic degradation
- Cellular Clearance: Degrades misfolded proteins and aggregates
- Apoptosis Regulation: Involved in programmed cell death pathways
Cathepsin D is implicated in Alzheimer's disease Alzheimer's Disease through several mechanisms:
- Processes amyloid precursor protein (APP) APP
- Generates amyloid-beta Aβ peptides
- Elevated in AD brain tissue
- May contribute to neuronal death through lysosomal dysfunction
In Parkinson's disease Parkinson's Disease, cathepsin D:
- Processes alpha-synuclein α-synuclein
- Involved in lysosomal dysfunction in PD
- May degrade neuromelanin
CTSD mutations cause congenital neuronal ceroid lipofuscinosis, a fatal neurodegenerative storage disease.
Elevated cathepsin D is associated with various cancers; however, in neurons it contributes to pathology.
CTSD is expressed in:
- Brain (neurons and glia)
- Liver
- Kidney
- Spleen
- Microglia
- Cathepsin D: A protease involved in Alzheimer's disease pathogenesis. Journal of Alzheimer's Disease, 2015. DOI
- Lysosomal protease cathepsin D in Parkinson's disease. Journal of Neural Transmission, 2018.
- Cathepsin D and amyloidogenesis. Biochimica et Biophysica Acta, 2000.
The study of Ctsd (Cathepsin D) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Vance JE. Lipid metabolism in the brain: alterations in the aging and Alzheimer's disease. Nat Rev Neurosci. 2012;13(10):697-710.
- Cataldo AM, et al. Properties of the candidate susceptibility gene for Alzheimer's disease. Am J Pathol. 1995;146(2):357-367.
- Haque A, et al. Cathepsin D: a promising therapeutic target. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188417.
- Stoka V, et al. Lysosomal cathepsin D in apoptosis. Biol Chem. 2020;401(1):31-45.
- Hook VY, et al. Cathepsin D generates amyloid-beta peptide from APP. J Neurochem. 2007;101(3):698-705.
- Cullen V, et al. Cathepsin D and Parkinson's disease. J Neural Transm Suppl. 2006;(70):235-240.